Ekaterina Gresko

763 total citations
15 papers, 610 citations indexed

About

Ekaterina Gresko is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ekaterina Gresko has authored 15 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Hematology. Recurrent topics in Ekaterina Gresko's work include Cancer-related Molecular Pathways (6 papers), Cell death mechanisms and regulation (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ekaterina Gresko is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Cell death mechanisms and regulation (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ekaterina Gresko collaborates with scholars based in Switzerland, Germany and Italy. Ekaterina Gresko's co-authors include Anton Vichalkovski, Brian A. Hemmings, M. Lienhard Schmitz, Ana Roscic, Andreas Möller, Alexander Hergovich, Debora Schmitz, Hauke Cornils, David F. Restuccia and Marco A. Calzado and has published in prestigious journals such as The EMBO Journal, Blood and Molecular Cell.

In The Last Decade

Ekaterina Gresko

13 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ekaterina Gresko Switzerland	11	425	273	144	83	69	15	610
Michael D. Rainey Ireland	16	615 1.4×	315 1.2×	173 1.2×	112 1.3×	56 0.8×	26	779
Tanya Bondar United States	8	451 1.1×	223 0.8×	155 1.1×	92 1.1×	114 1.7×	9	676
Jan Benada Denmark	11	460 1.1×	245 0.9×	114 0.8×	96 1.2×	26 0.4×	14	566
Evangelia Loizou United States	7	548 1.3×	243 0.9×	61 0.4×	118 1.4×	66 1.0×	8	775
Andrea Bisso Italy	10	518 1.2×	291 1.1×	78 0.5×	159 1.9×	54 0.8×	17	692
Cecilia Grimaldi Italy	13	517 1.2×	119 0.4×	98 0.7×	81 1.0×	75 1.1×	17	723
Calvina Kek Singapore	7	568 1.3×	412 1.5×	85 0.6×	121 1.5×	35 0.5×	7	683
Celine Ngouenet United States	5	862 2.0×	208 0.8×	150 1.0×	146 1.8×	48 0.7×	9	975
Thomas Schleker Switzerland	9	879 2.1×	306 1.1×	183 1.3×	120 1.4×	39 0.6×	10	962
Mulu Geletu Canada	13	392 0.9×	188 0.7×	79 0.5×	57 0.7×	49 0.7×	35	534

Countries citing papers authored by Ekaterina Gresko

Since Specialization

Citations

This map shows the geographic impact of Ekaterina Gresko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekaterina Gresko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekaterina Gresko more than expected).

Fields of papers citing papers by Ekaterina Gresko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekaterina Gresko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekaterina Gresko. The network helps show where Ekaterina Gresko may publish in the future.

Co-authorship network of co-authors of Ekaterina Gresko

This figure shows the co-authorship network connecting the top 25 collaborators of Ekaterina Gresko. A scholar is included among the top collaborators of Ekaterina Gresko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekaterina Gresko. Ekaterina Gresko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vera, Ana de, Paula R. Clemens, Utkarsh J. Dang, et al.. (2025). Mineralocorticoid receptor antagonism of vamorolone: Evidence from LIONHEART and VISION-DMD clinical trials. Steroids. 223. 109689–109689.

Klamroth, Robert, Patricia Guyot, A. Arnaud, et al.. (2023). PB0201 Efanesoctocog Alfa Versus Extended Half-Life Factor VIII Therapies for Prophylaxis in Adolescents and Adults with Severe Hemophilia A: A Matching-Adjusted Indirect Comparison and Meta-Analysis. Research and Practice in Thrombosis and Haemostasis. 7. 101290–101290. 1 indexed citations

Peyvandi, Flora, Cristina Tarango, Mindy Simpson, et al.. (2023). Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children <12 Years of Age with Severe Hemophilia A. Blood. 142(Supplement 1). 506–506.

Bosch, Francesc, Guy Cantin, Agostino Cortelezzi, et al.. (2019). Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study. Leukemia. 34(2). 441–450. 6 indexed citations

Stilgenbauer, Stephan, Véronique Leblond, Robin Foà, et al.. (2018). Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study. Leukemia. 32(8). 1778–1786. 20 indexed citations

Leblond, Véronique, Melih Aktan, Caroline Dartigeas, et al.. (2018). Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study. Haematologica. 103(11). 1889–1898. 13 indexed citations

Azim, Hatem A., Otto Metzger, Evandro de Azambuja, et al.. (2012). Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01). Breast Cancer Research and Treatment. 133(1). 387–391. 53 indexed citations

Vichalkovski, Anton, et al.. (2010). PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage. Oncogene. 29(24). 3554–3565. 106 indexed citations

Vichalkovski, Anton, Ekaterina Gresko, Hauke Cornils, et al.. (2008). NDR Kinase Is Activated by RASSF1A/MST1 in Response to Fas Receptor Stimulation and Promotes Apoptosis. Current Biology. 18(23). 1889–1895. 134 indexed citations

10.

Gresko, Ekaterina, et al.. (2008). PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene. 28(5). 698–708. 33 indexed citations

11.

Gresko, Ekaterina, et al.. (2006). Autoregulatory control of the p53 response by caspase‐mediated processing of HIPK2. The EMBO Journal. 25(9). 1883–1894. 60 indexed citations

12.

Roscic, Ana, Andreas Möller, Marco A. Calzado, et al.. (2006). Phosphorylation-Dependent Control of Pc2 SUMO E3 Ligase Activity by Its Substrate Protein HIPK2. Molecular Cell. 24(1). 77–89. 98 indexed citations

13.

Gresko, Ekaterina, Andreas Möller, Ana Roscic, & M. Lienhard Schmitz. (2005). Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochemical and Biophysical Research Communications. 329(4). 1293–1299. 39 indexed citations

14.

Bisoffi, Marco, Irena Klima, Ekaterina Gresko, et al.. (2004). EXPRESSION PROFILES OF ANDROGEN INDEPENDENT BONE METASTATIC PROSTATE CANCER CELLS INDICATE UP-REGULATION OF THE PUTATIVE SERINE-THREONINE KINASE GS3955. The Journal of Urology. 172(3). 1145–1150. 12 indexed citations

15.

Möller, Andreas, Hüseyin Sirma, Thomas G. Hofmann, et al.. (2003). Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression. Oncogene. 22(54). 8731–8737. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact